Technology Platforms
Our integrated technology platforms can enable an unprecedented breadth of advanced therapies, including gene therapies, autologous and allogeneic cell therapies, and induced pluripotent stem cells (iPSCs)-derived regenerative therapies.
// Technology
Platforms
Enabling the Therapies of the Future
ElevateBio® is a technology-forward company founded on the belief that cell and gene therapies are the medicine of the future. We’ve assembled a suite of integrated enabling technologies that enables us and our biopharmaceutical industry partners to discover, develop, manufacture, and commercialize a broad spectrum of next-generation cell and gene therapies.
Learn more about
Gene Editing
We have a powerful suite of gene editing technologies to accelerate the development of life-changing and curative therapies for patients. We aspire to broadly apply and make accessible several modalities, including double-strand breaks, base editing, and reverse transcriptase (RT) editing to modify gene targets both in vivo and ex vivo.
Induced Pluripotent Stem Cells (iPSCs)
We are setting a new standard with well-characterized induced pluripotent stem cell (iPSC) lines that are produced in stroma-free, xeno-free, and serum-free conditions. Our iPSC lines are suitable for research, clinical and commercial use and have the potential to reduce manufacturing risks, regulatory hurdles, as well as save time and costs in the development of iPSC-derived therapies.
RNA, Cell, Protein, & Vector Engineering
We have built additional enabling technology platforms, including RNA, cell, protein, and vector engineering, that are essential to the construct and design of cell and gene therapies. We have centralized these platforms to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
Our Therapeutic Approaches
We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.
End-to-End Capabilities
We help our partners scale new heights in cell and gene therapies by providing a full spectrum of viral vector and cell therapy capabilities to bring concepts to commercialization.
Team of Industry-Leading Experts
We have assembled a leading team of experts with first-hand experience in the discovery, development, and manufacturing of cell and gene therapies. Driven by a common mission to power life-changing therapies, the team works to advance discoveries and development at a speed the world demands.
Partner with ElevateBio®
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us
